Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer
Open Access
- 21 June 2004
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (2) , 203-211
- https://doi.org/10.1111/j.1365-2036.2004.01826.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity islandAmerican Journal of Gastroenterology, 2002
- Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patientsGut, 2002
- Natural history and epidemiology ofHelicobacter pyloriinfectionAlimentary Pharmacology & Therapeutics, 2002
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Cellular responses induced after contact with Helicobacter pyloriCurrent Opinion in Microbiology, 2001
- Helicobacter pylori Virulence and Genetic GeographyScience, 1999
- Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pyloriGastroenterology, 1998
- Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A modelGastroenterology, 1997
- The Interrelationship between Cytotoxin-Associated Gene A, Vacuolating Cytotoxin, and Helicobacter pylori-Related DiseasesThe Journal of Infectious Diseases, 1996
- Helicobacter pylori and Atrophic Gastritis: Importance of the cagA StatusJNCI Journal of the National Cancer Institute, 1995